Reversal of Aberrant Cancer Methylome and Transcriptome upon Direct Reprogramming of Lung Cancer Cells

被引:37
作者
Mahalingam, Dashayini [1 ]
Kong, Chiou Mee [1 ]
Lai, Jason [1 ]
Tay, Ling Lee [1 ]
Yang, Henry [2 ]
Wang, Xueying [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore
[2] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
关键词
PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; METHYLATION; THERAPY; GENOME; ES;
D O I
10.1038/srep00592
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent reports on direct reprogramming of cancer cells (iPCs) which results in reduced tumorigenic potential has attributed the importance of epigenetics in tumorigenesis, but lacked genome-wide analysis. Here we describe successful generation of iPCs from non-small cell lung cancer (NSCLC) cell lines. Following reprogramming, they resembled embryonic stem and induced pluripotent stem cells in pluripotency markers expression, gene expression patterns and in vitro differentiation ability. Genome-wide methylation analysis revealed that aberrantly methylated promoters which were mostly developmental-associated genes and tumor suppressors; as well as commonly upregulated genes in NSCLC i.e. KRT19 and S100P were reversed in iPCs upon reprogramming. Also, the reversal of oncogenes and tumor suppressors status were partially explainable by DNA methylation. These findings suggest that DNA methylation patterns explain the downstream transcriptional effects, which potentially caused the reduced tumorigenicity in iPCs, thus providing evidence that reprogramming reverses the aberrantly dysregulated genes in NSCLC both epigenetically and transcriptionally.
引用
收藏
页数:10
相关论文
共 56 条
  • [1] Blocking oncogenic Ras signaling for cancer therapy
    Adjei, AA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14): : 1062 - 1074
  • [2] Epigenetic reprogramming of breast cancer cells with oocyte extracts
    Allegrucci, Cinzia
    Rushton, Michael D.
    Dixon, James E.
    Sottile, Virginie
    Shah, Mansi
    Kumari, Rajendra
    Watson, Sue
    Alberio, Ramiro
    Johnson, Andrew D.
    [J]. MOLECULAR CANCER, 2011, 10
  • [3] [Anonymous], 2011, R: A Language and Environment for Statistical Computing
  • [4] [Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
  • [5] S100P: a novel therapeutic target for cancer
    Arumugam, Thiruvengadam
    Logsdon, Craig D.
    [J]. AMINO ACIDS, 2011, 41 (04) : 893 - 899
  • [6] Oncogenic pathway signatures in human cancers as a guide to targeted therapies
    Bild, AH
    Yao, G
    Chang, JT
    Wang, QL
    Potti, A
    Chasse, D
    Joshi, MB
    Harpole, D
    Lancaster, JM
    Berchuck, A
    Olson, JA
    Marks, JR
    Dressman, HK
    West, M
    Nevins, JR
    [J]. NATURE, 2006, 439 (7074) : 353 - 357
  • [7] Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines
    Bock, Christoph
    Kiskinis, Evangelos
    Verstappen, Griet
    Gu, Hongcang
    Boulting, Gabriella
    Smith, Zachary D.
    Ziller, Michael
    Croft, Gist F.
    Amoroso, Mackenzie W.
    Oakley, Derek H.
    Gnirke, Andreas
    Eggan, Kevin
    Meissner, Alexander
    [J]. CELL, 2011, 144 (03) : 439 - 452
  • [8] A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
    Bolstad, BM
    Irizarry, RA
    Åstrand, M
    Speed, TP
    [J]. BIOINFORMATICS, 2003, 19 (02) : 185 - 193
  • [9] Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas
    Camilo, R
    Capelozzi, VL
    Siqueira, SAC
    Del Carlo Bernardi, F
    [J]. HUMAN PATHOLOGY, 2006, 37 (05) : 542 - 546
  • [10] Generation of iPSCs from cultured human malignant cells
    Carette, Jan E.
    Pruszak, Jan
    Varadarajan, Malini
    Blomen, Vincent A.
    Gokhale, Sumita
    Camargo, Fernando D.
    Wernig, Marius
    Jaenisch, Rudolf
    Brummelkamp, Thijn R.
    [J]. BLOOD, 2010, 115 (20) : 4039 - 4042